Eva Tiensuu Janson

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Papantoniou, Dimitrios; Fröss-Baron, Katarzyna; Garske Roman, Ulrike; Sundin, Anders et al.

Part of Journal of neuroendocrinology, 2024

• DOI for Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
• Download full text (pdf) of Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

Wedin, Maria; Tiensuu Janson, Eva; Wallin, Göran; Sundin, Anders et al.

Part of Journal of neuroendocrinology, 2024

• DOI for Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours
• Download full text (pdf) of Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours

Lamarca, Angela; Bartsch, Detlef K.; Caplin, Martyn; Kos‐Kudla, Beata et al.

Part of Journal of neuroendocrinology, 2024

• DOI for European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5

Hadoux, J.; Lamarca, A.; Grande, E.; Deandreis, D. et al.

Part of ESMO Open, 2024

• DOI for Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5
• Download full text (pdf) of Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

Papantoniou, Dimitrios; Grönberg, Malin; Thiis-Evensen, Espen; Sorbye, Halfdan et al.

Part of Endocrine-Related Cancer, 2023

• DOI for Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
• Download full text (pdf) of Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Papantoniou, Dimitrios; Fröss-Baron, Katarzyna; Garske Roman, Ulrike; Sundin, Anders et al.

Part of Journal of neuroendocrinology, 2024

• DOI for Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
• Download full text (pdf) of Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients

Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

Wedin, Maria; Tiensuu Janson, Eva; Wallin, Göran; Sundin, Anders et al.

Part of Journal of neuroendocrinology, 2024

• DOI for Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours
• Download full text (pdf) of Prevalence of metastases outside the liver and abdominal lymph nodes on ⁶⁸Ga-DOTATOC-PET/CT in patients with small intestinal and pancreatic neuroendocrine tumours

European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours

Lamarca, Angela; Bartsch, Detlef K.; Caplin, Martyn; Kos‐Kudla, Beata et al.

Part of Journal of neuroendocrinology, 2024

• DOI for European Neuroendocrine Tumor Society (ENETS) 2024 guidance paper for the management of well-differentiated small intestine neuroendocrine tumours

Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5

Hadoux, J.; Lamarca, A.; Grande, E.; Deandreis, D. et al.

Part of ESMO Open, 2024

• DOI for Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5
• Download full text (pdf) of Neuroendocrine neoplasms of head and neck, genitourinary and gynaecological systems, unknown primaries, parathyroid carcinomas and intrathyroid thymic neoplasms: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up5

Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

Papantoniou, Dimitrios; Grönberg, Malin; Thiis-Evensen, Espen; Sorbye, Halfdan et al.

Part of Endocrine-Related Cancer, 2023

• DOI for Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
• Download full text (pdf) of Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort

European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma

Sorbye, Halfdan; Grande, Enrique; Pavel, Marianne; Tesselaar, Margot et al.

Part of Journal of neuroendocrinology, 2023

• DOI for European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma
• Download full text (pdf) of European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for digestive neuroendocrine carcinoma

Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Dam, Gitte; Grønbæk, Henning; Sundlöv, Anna; Botling, Johan et al.

Part of Acta Oncologica, p. 431-437, 2023

• DOI for Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms.

Loss of Y in leukocytes as a risk factor for critical COVID-19 in men

Bruhn-Olszewska, Bozena; Davies, Hanna; Sarkisyan, Daniil; Juhas, Ulana et al.

Part of Genome Medicine, 2022

• DOI for Loss of Y in leukocytes as a risk factor for critical COVID-19 in men
• Download full text (pdf) of Loss of Y in leukocytes as a risk factor for critical COVID-19 in men

Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2

Papantoniou, Dimitrios; Grönberg, Malin; Landerholm, Kalle; Welin, Staffan et al.

Part of Endocrine, p. 893-904, 2021

• DOI for Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2
• Download full text (pdf) of Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2

A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Elvebakken, Hege; Perren, Aurel; Scoazec, Jean-Yves; Tang, Laura H. et al.

Part of Neuroendocrinology, p. 883-894, 2021

• DOI for A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations

Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre

Lase, Ieva; Grönberg, Malin; Norlén, Olov; Stålberg, Peter et al.

Part of Journal of neuroendocrinology, 2021

• DOI for Adrenalectomy in ectopic Cushing's syndrome: A retrospective cohort study from a tertiary care centre

Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms

Pommergaard, Hans-Christian; Nielsen, Kirstine; Sorbye, Halfdan; Federspiel, Birgitte et al.

Part of Journal of neuroendocrinology, 2021

• DOI for Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms

Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Tiensuu Janson, Eva; Knigge, Ulrich; Dam, Gitte; Federspiel, Birgitte et al.

Part of Acta Oncologica, p. 931-941, 2021

• DOI for Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
• Download full text (pdf) of Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Perren, Aurel; Lindskog, Cecilia; Welin, Staffan et al.

Part of Scientific Reports, 2020

• DOI for Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
• Download full text (pdf) of Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Ali, Abir Salwa; Langer, Seppo W.; Federspiel, Birgitte; Hjortland, Geir Olav et al.

Part of PLOS ONE, 2020

• DOI for PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
• Download full text (pdf) of PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3

Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome

Lase, Ieva; Strele, Ieva; Grönberg, Malin; Kozlovacki, Gordana et al.

Part of Hormones, p. 351-360, 2020

• DOI for Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome
• Download full text (pdf) of Multiple hormone secretion may indicate worse prognosis in patients with ectopic Cushing's syndrome

Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors

Dam, Gitte; Gronbaek, Henning; Sorbye, Halfdan; Evensen, Espen Thiis et al.

Part of Neuroendocrinology, p. 217-224, 2020

• DOI for Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors

Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Georgantzi, Kleopatra; Tsolakis, Apostolos V.; Jakobson, Åke; Christofferson, Rolf et al.

Part of Endocrine pathology, p. 173-179, 2019

• DOI for Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma
• Download full text (pdf) of Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma: a safe and efficient procedure

Georgantzi, Kleopatra; Sköldenberg, Erik; Tiensuu Janson, Eva; Jakobson, Åke et al.

Part of Journal of Pediatric Surgery, p. 1253-1256, 2019

• DOI for Diagnostic Ultrasound-Guided Cutting Needle Biopsies in Neuroblastoma: a safe and efficient procedure

Unmet Needs in Appendiceal Neuroendocrine Neoplasms

Toumpanakis, Christos; Fazio, Nicola; Tiensuu Janson, Eva; Hörsch, Dieter et al.

Part of Neuroendocrinology, p. 37-44, 2019

• DOI for Unmet Needs in Appendiceal Neuroendocrine Neoplasms

Ghrelin expression is associated with a favorable outcome in male breast cancer

Grönberg, Malin; Nilsson, Cecilia; Markholm, Ida; Hedenfalk, Ingrid et al.

Part of Scientific Reports, 2018

• DOI for Ghrelin expression is associated with a favorable outcome in male breast cancer
• Download full text (pdf) of Ghrelin expression is associated with a favorable outcome in male breast cancer

Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Ali, Abir Salwa; Grönberg, Malin; Langer, Seppo W.; Ladekarl, Morten et al.

Part of Medical Oncology, 2018

• DOI for Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)
• Download full text (pdf) of Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)

Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.

Georgantzi, Kleopatra; Sköldenberg, Erik; Stridsberg, Mats; Kogner, Per et al.

Part of Pediatric Hematology & Oncology, p. 156-165, 2018

• DOI for Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.
• Download full text (pdf) of Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors.

Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

Ali, Abir A.; Grönberg, Malin; Hjortland, G. O.; Grønbæk, H. et al.

Part of Neuroendocrinology, p. 184-184, 2018

• DOI for Intravenous versus Oral Etoposide: Efficacy and Correlation to Clinical Outcome in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (WHO G3)

A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors

Dam, G.; Grønbæk, H.; Sørbye, H.; Thiis-Evensen, E. et al.

Part of Neuroendocrinology, p. 152-152, 2018

• DOI for A Prospective Nordic Study on the Use of Chromogranin A for the Prediction of Progression in Patients with Pancreatic and Small Intestinal Neuroendocrine Tumors

Association of a Prophylactic surgical approach to Stage IV Small Intestinal Neuroendocrine Tumors with Survival.

Daskalakis, Kosmas; Karakatsanis, Andreas; Hessman, Ola; Stuart, Heather C. et al.

Part of JAMA Oncology, p. 183-189, 2018

• DOI for Association of a Prophylactic surgical approach to Stage IV Small Intestinal Neuroendocrine Tumors with Survival.

Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer

Grönberg, Malin; Ahlin, Cecilia; Naeser, Ylva; Tiensuu Janson, Eva et al.

Part of PLOS ONE, 2017

• DOI for Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer
• Download full text (pdf) of Ghrelin is a prognostic marker and a potential therapeutic target in breast cancer

Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

Ali, Abir Salwa; Grönberg, Malin; Federspiel, Birgitte; Scoazec, Jean-Yves et al.

Part of PLOS ONE, 2017

• DOI for Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma
• Download full text (pdf) of Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma

DcR3, TFF3 and Midkine are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

Edfeldt, Katarina; Daskalakis, Kosmas; Bäcklin, Christofer; Norlén, Olov et al.

Part of Neuroendocrinology, p. 170-181, 2017

• DOI for DcR3, TFF3 and Midkine are Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

Dumanski, Jan P.; Rasi, Chiara; Björklund, Peyman; Davies, Hanna et al.

Part of Endocrine-Related Cancer, p. 427-443, 2017

• DOI for A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors
• Download full text (pdf) of A MUTYH germline mutation is associated with small intestinal neuroendocrine tumors

Resection of Liver Metastases in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinomas: A Nordic Multicenter Study

Galleberg, R. B.; Knigge, U.; Tiensuu Janson, Eva; Vestermark, L. W. et al.

Part of Neuroendocrinology, p. 264-264, 2017

Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas

Galleberg, R. B.; Knigge, U.; Tiensuu Janson, Eva; Vestermark, L. W. et al.

Part of European Journal of Surgical Oncology, p. 1682-1689, 2017

• DOI for Results after surgical treatment of liver metastases in patients with high-grade gastroenteropancreatic neuroendocrine carcinomas

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

Kaltsas, Gregory; Caplin, Martyn; Davies, Philippa; Ferone, Diego et al.

Part of Neuroendocrinology, p. 245-254, 2017

• DOI for ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors
• Download full text (pdf) of ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Pre- and Perioperative Therapy in Patients with Neuroendocrine Tumors

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

Hicks, Rodney J.; Kwekkeboom, Dik J.; Krenning, Eric; Bodei, Lisa et al.

Part of Neuroendocrinology, p. 295-309, 2017

• DOI for ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

Expression of Mutated p53 Protein in Gastroenteropancreatic Neuroendocrine Carcinoma (WHO G3)

Ali, Abir; Grönberg, Malin; Federspiel, B.; Hjortland, G. O. et al.

Part of Neuroendocrinology, p. 43-43, 2016

Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours

Söderquist, Fanny; Tiensuu Janson, Eva; Rasmusson, Annica; Alit, Abir et al.

Part of PLOS ONE, 2016

• DOI for Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours
• Download full text (pdf) of Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours

Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study

Haugvik, Sven-Petter; Janson, Eva Tiensuu; Osterlund, Pia; Langer, Seppo W. et al.

Part of Annals of Surgical Oncology, p. 1721-1728, 2016

• DOI for Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study

Midkine Is a New Novel Serum Biomarker in Small Intestinal Neuroendocrine Tumors (SI-NETs)

Daskalakis, Kosmas; Edfeldt, Katarina; Norlén, Olov; Karakatsanis, Andreas et al.

Part of Neuroendocrinology, p. 45-45, 2016

Mutagenesis: smoking is associated with mosaic loss of chromosome Y

Dumanski, Jan P.; Rasi, Chiara; Lönn, Mikael; Davies, Hanna et al.

Part of Science, p. 81-83, 2015

• DOI for Mutagenesis: smoking is associated with mosaic loss of chromosome Y

Histidine decarboxylase and urinary methylimidazoleacetic acid in gastric neuroendocrine cells and tumours

Tsolakis, Apostolos V.; Grimelius, Lars; Granerus, Goran; Stridsberg, Mats et al.

Part of World Journal of Gastroenterology, p. 13240-13249, 2015

• DOI for Histidine decarboxylase and urinary methylimidazoleacetic acid in gastric neuroendocrine cells and tumours

Somatostatin receptor 1-5; expression profiles during rat development

Ludvigsen, Eva; Carlsson, Carina; Janson, Eva Tiensuu; Sandler, Stellan et al.

Part of Upsala Journal of Medical Sciences, p. 157-168, 2015

• DOI for Somatostatin receptor 1-5; expression profiles during rat development

Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer

Forsberg, Lars A.; Rasi, Chiara; Pekar, Gyula; Davies, Hanna et al.

Part of Genome Research, p. 1521-1535, 2015

• DOI for Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer
• Download full text (pdf) of Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer

Forsberg, Lars A.; Rasi, Chiara; Malmqvist, Niklas; Davies, Hanna et al.

Part of Nature Genetics, p. 624-628, 2014

• DOI for Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer

TCEB3C a putative tumor suppressor gene of small intestine neuroendocrine tumors

Edfeldt, Katarina; Ahmad, Tanveer; Åkerström, Göran; Janson, Eva T et al.

Part of Endocrine-Related Cancer, p. 275-284, 2014

• DOI for TCEB3C a putative tumor suppressor gene of small intestine neuroendocrine tumors

Treatment with somatostatin analogues may delay progression of neuroendocrine tumours

Janson, Eva Tiensuu

Part of Acta Oncologica, p. 1283-1283, 2014

• DOI for Treatment with somatostatin analogues may delay progression of neuroendocrine tumours

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study

Sorbye, H; Welin, Staffan; Langer, S.W.; Vestermark, L.W. et al.

Part of Annals of Oncology, p. 152-160, 2013

• DOI for Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study

Ki-67 Proliferative Index Predicts Response to Chemotherapy and Survival in 252 Patients with High-Grade Gastrointestinal Neuroendocrine Carcinoma (WHO G3)

Sorbye, Halfdan; Welin, Staffan; Langer, Seppo; Vestermark, Lena et al.

Part of Pancreas, p. 382-382, 2013

Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake

Grönberg, Malin; Tsolakis, Apostolos V; Holmbäck, Ulf; Stridsberg, Mats et al.

Part of Neuroendocrinology, p. 291-299, 2013

• DOI for Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake
• Download full text (pdf) of Ghrelin and Obestatin in Human Neuroendocrine Tumors: Expression and Effect on Obestatin Levels after Food Intake

TCEB3C (Elongin A3) on chromosome 18 presents a putative tumor suppressor gene of small intestine neuroendocrine tumors.

Edfeldt, Katarina; Ahmad, Tanvver; Åkerstrom, Göran; Janson, Eva Tiensuu et al.

Part of Cancer Research, 2013

• DOI for TCEB3C (Elongin A3) on chromosome 18 presents a putative tumor suppressor gene of small intestine neuroendocrine tumors.

Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center

Norlén, Olov; Stålberg, Peter; Öberg, Kjell; Eriksson, John et al.

Part of World Journal of Surgery, p. 1419-1431, 2012

• DOI for Long-Term Results of Surgery for Small Intestinal Neuroendocrine Tumors at a Tertiary Referral Center

Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer

Grönberg, Malin; Fjällskog, Marie-Louise; Jirström, Karin; Tiensuu Janson, Eva

Part of Acta Oncologica, p. 386-393, 2012

• DOI for Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer

Somatostatin receptor expression in non-medullary thyroid carcinomas

Pazaitou-Panayiotou, Kalliopi; Tiensuu Janson, Eva; Koletsa, Triantafyllia; Kotoula, Vassiliki et al.

Part of Hormones, p. 290-296, 2012

Altered Expression of Somatostatin Receptors in Pancreatic Islets from NOD Mice Cultured at Different Glucose Concentrations In Vitro and in Islets Transplanted to Diabetic NOD Mice In Vivo

Ludvigsen, Eva; Stridsberg, Mats; Janson, Eva T.; Sandler, Stellan

Part of Experimental Diabetes Research, p. 623472, 2011

• DOI for Altered Expression of Somatostatin Receptors in Pancreatic Islets from NOD Mice Cultured at Different Glucose Concentrations In Vitro and in Islets Transplanted to Diabetic NOD Mice In Vivo

Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors

Cunningham, Janet L.; Díaz de Ståhl, Teresita; Sjöblom, Tobias; Westin, Gunnar et al.

Part of Genes, Chromosomes and Cancer, p. 82-94, 2011

• DOI for Common pathogenetic mechanism involving human chromosome 18 in familial and sporadic ileal carcinoid tumors

Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma

Georgantzi, Kleopatra; Tsolakis, Apostolos V; Stridsberg, Mats; Jakobson, Åke et al.

Part of Pediatric Blood & Cancer, p. 584-589, 2011

• DOI for Differentiated expression of somatostatin receptor subtypes in experimental models and clinical neuroblastoma

A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum

Walsh, Kyle M.; Choi, Murim; Öberg, Kjell E.; Kulke, Matthew H. et al.

Part of Endocrine-Related Cancer, p. 171-180, 2011

• DOI for A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum

Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)

Kindmark, Henrik; Janson, Eva Tiensuu; Gustavsson, Bengt; Eriksson, Camilla et al.

Part of Acta Oncologica, p. 100-101, 2010

• DOI for Five patients with malignant endocrine tumors treated with imatinib mesylate (Glivec®)

Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of alpha-smooth muscle actin

Cunningham, Janet L.; Tsolakis, Apostolos V.; Jacobson, Annica; Janson, Eva Tiensuu

Part of European Journal of Endocrinology, p. 691-697, 2010

• DOI for Connective tissue growth factor expression in endocrine tumors is associated with high stromal expression of alpha-smooth muscle actin

Neuroendocrine markers are expressed in human mammary glands

Grönberg, Malin; Amini, Rose-Marie; Stridsberg, Mats; Janson, Eva Tiensuu et al.

Part of Regulatory Peptides, p. 68-74, 2010

• DOI for Neuroendocrine markers are expressed in human mammary glands

Chromogranin A is a Sensitive Marker for Detection of Recurrence in Neuroendocrine Tumors

Janson, Eva Tiensuu; Welin, Staffan; Eriksson, Barbro; Stridsberg, Mats

Part of Neuroendocrinology, p. 63-63, 2010

• DOI for Chromogranin A is a Sensitive Marker for Detection of Recurrence in Neuroendocrine Tumors

Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach

Tsolakis, Apostolos V.; Grimelius, Lars; Stridsberg, Mats; Falkmer, Sture E. et al.

Part of European Journal of Endocrinology, p. 941-949, 2009

• DOI for Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach

Elevated Plasma Chromogranin A is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumours

Welin, Staffan; Stridsberg, Mats; Cunningham, Janet; Granberg, Dan et al.

Part of Neuroendocrinology, p. 302-307, 2009

• DOI for Elevated Plasma Chromogranin A is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumours

Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life

Larsson, Gunnel; Janson, Eva Tiensuu

Part of European Journal of Cancer Care, p. 200-204, 2008

• DOI for Anemia in patients with midgut carcinoid, treated with alpha interferon: effects by erythropoietin treatment on the perceived quality of life

Ghrelin Immunoreactive Cells in Gastric Endocrine Tumors and Their Relation to Plasma Ghrelin Concentration: Ghrelin in Gastric Endocrine Tumors

Tsolakis, Apostolos V.; Stridsberg, Mats; Grimelius, Lars; Portela-Gomes, Guida M. et al.

Part of Journal of Clinical Gastroenterology, p. 381-388, 2008

• DOI for Ghrelin Immunoreactive Cells in Gastric Endocrine Tumors and Their Relation to Plasma Ghrelin Concentration: Ghrelin in Gastric Endocrine Tumors

Endocrine Pancreatic Tumors: Diagnosis and Treatment

Tsolakis, Apostolos V; Janson, Eva Tiensuu

Part of Expert review of endocrinology & metabolism, p. 187-205, 2008

• DOI for Endocrine Pancreatic Tumors: Diagnosis and Treatment

Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands

Grönberg, Malin; Tsolakis, Apostolos; Magnusson, Linda; Janson, Eva Tiensuu et al.

Part of Journal of Histochemistry and Cytochemistry, p. 793-801, 2008

• DOI for Distribution of obestatin and ghrelin in human tissues: immunoreactive cells in the gastrointestinal tract, pancreas, and mammary glands

Treatment with Combined Streptozotocin and Liposomal Doxorubicin in Metastatic Endocrine Pancreatic Tumors

Fjällskog, Marie-Louise H.; Janson, Eva Tiensuu; Falkmer, Ursula G.; Vatn, Morten H. et al.

Part of Neuroendocrinology, p. 53-8, 2008

• DOI for Treatment with Combined Streptozotocin and Liposomal Doxorubicin in Metastatic Endocrine Pancreatic Tumors

Tachykinins in endocrine tumors and the carcinoid syndrome

Cunningham, Janet L.; Janson, Eva Tiensuu; Agarwal, Smriti; Grimelius, Lars et al.

Part of European Journal of Endocrinology, p. 275-282, 2008

• DOI for Tachykinins in endocrine tumors and the carcinoid syndrome

Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours

Stridsberg, Mats; Eriksson, Barbro; Janson, Eva Tiensuu

Part of Regulatory Peptides, p. 95-98, 2008

• DOI for Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

Ekeblad, Sara; Sundin, Anders; Janson, Eva Tiensuu; Welin, Staffan et al.

Part of Clinical Cancer Research, p. 2986-2991, 2007

• DOI for Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

Kindmark, Henrik; Sundin, Anders; Granberg, Dan; Dunder, Kristina et al.

Part of Medical Oncology, p. 330-337, 2007

• DOI for Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas: predominance of receptor subtype 4

Portela-Gomes, Guida Maria; Stridsberg, Mats; Grimelius, Lars; Rorstad, Otto et al.

Part of Endocrine pathology, p. 79-85, 2007

• DOI for Differential expression of the five somatostatin receptor subtypes in human benign and malignant insulinomas: predominance of receptor subtype 4

Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors

Granberg, Dan; Eriksson, Lars-Gunnar; Welin, Staffan; Kindmark, Henrik et al.

Part of Acta Radiologica, p. 180-185, 2007

• DOI for Liver embolization with trisacryl gelatin microspheres (embosphere) in patients with neuroendocrine tumors

Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis

Cunningham, Janet Lynn; Grimelius, Lars; Sundin, Anders; Agarwal, Smriti et al.

Part of Acta Oncologica, p. 747-756, 2007

• DOI for Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis

Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues

Ludvigsen, Eva; Stridsberg, Mats; Taylor, John; Culler, Michael et al.

Part of Regulatory Peptides, p. 1-9, 2007

• DOI for Regulation of insulin and glucagon secretion from rat pancreatic islets in vitro by somatostatin analogues

Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas

Fjällskog, Marie-Louise; Hessman, Ola; Eriksson, Barbro; Janson, Eva Tiensuu

Part of Acta Oncologica, p. 741-746, 2007

• DOI for Upregulated expression of PDGF receptor beta in endocrine pancreatic tumors and metastases compared to normal endocrine pancreas

Somatostatin induces rapid contraction of neuroendocrine cells

Saras, Jan; Grönberg, Malin; Stridsberg, Mats; Öberg, Kjell E. et al.

Part of FEBS Letters, p. 1957-1962, 2007

• DOI for Somatostatin induces rapid contraction of neuroendocrine cells

Measurements of chromogranin B can serve as a complement to chromogranin A

Stridsberg, Mats; Eriksson, Barbro; Fellström, Bengt; Kristiansson, Gudjon et al.

Part of Regulatory Peptides, p. 80-83, 2007

• DOI for Measurements of chromogranin B can serve as a complement to chromogranin A

Lungcarcinoider: inte så benigna som man trott

Granberg, Dan; Eriksson, Barbro; Janson, Eva Tiensuu; Öberg, Kjell et al.

Part of Läkartidningen, p. 2382-2384, 2006

Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of nomoglycemic and diabetic NOD mice

Ludvigsen, Eva; Stridsberg, Mats; Tiensuu Janson, Eva; Sandler, Stellan

Part of European Journal of Endocrinology, p. 445-454, 2005

• DOI for Expression of somatostatin receptor subtypes 1-5 in pancreatic islets of nomoglycemic and diabetic NOD mice

Treatment of endocrine pancreatic tumors

Fjällskog, Marie-Louise; Tiensuu Janson, Eva

Part of Acta Oncologica, p. 329-338, 2005

• DOI for Treatment of endocrine pancreatic tumors

A panel of 13 region-specific radioimmunoassays for measurements of human chromogranin B.

Stridsberg, Mats; Eriksson, Barbro; Oberg, Kjell; Tiensuu Janson, Eva

Part of Regul Pept, p. 193-9, 2005

Expression of somatostatin receptor subtypes 1 to 5 in pancreatic islets of normoglycaemic diabetic NOD mice

Ludvigsen, Eva; Stridsberg, Mats; Tiensuu Janson, Eva; Sandler, Stellan

Part of European Journal of Endocrinology, p. 445-454, 2005

High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

Welin, Staffan; Janson, Eva Tiensuu; Sundin, Anders; Stridsberg, Mats et al.

Part of European Journal of Endocrinology, p. 107-112, 2004

• DOI for High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours

A panel of 11 region-specific radioimmunoassays for measurements of human chromogranin A.

Stridsberg, Mats; Eriksson, Barbro; Oberg, Kjell; Tiensuu Janson, Eva

Part of Regul Pept, p. 219-27, 2004

Cellular localisation of chromogranins and processed products in the diffuse neuroendocrine system and related tumours

Stridsberg, Mats; Tiensuu Janson, Eva; Portela-Gomes, Guida M.

Part of Curr. Med. Chem., p. 149-160, 2004

Subtype Selective Interactions of Somatostatin and Somatostatin Analogs with sst1, sst2, and sst5 in BON-1 Cells.

Ludvigsen, Eva; Stridsberg, Mats; Taylor, John E; Culler, Michael D et al.

Part of Med Oncol, p. 285-96, 2004

Expression and distribution of somatostatin receptor subtypes in the pancreatic islets of normal mice and rats

Ludvigsen, Eva; Olsson, R; Stridsberg, Mats; Tiensuu Janson, Eva et al.

Part of J Histochemistry and Cytochemistry, p. 391-400, 2004

Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors

Fjällskog, Marie-Louise; Ludvigsen, Eva; Stridsberg, Mats; Öberg, Kjell et al.

Part of Medical Oncology, p. 59-67, 2003

• DOI for Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors

Expression of molecular targets for tyrosine kinase receptor antagonistsin malignant endocrine pancreatic tumors

Fjallskog, Marie-Louise; Lejonklou, Margareta Halin; Öberg, Kjell E; Eriksson, BK et al.

Part of Clinical Cancer Research, p. 1469-1473, 2003

Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue andintratumoral vessels in malignant endocrine pancreatic tumors.

Fjallskog, ML; Ludvigsen, E; Stridsberg, M; Oberg, K et al.

Part of Med Oncol, p. 59, 2003

Octreoscan in patients with bronchial carcinoid tumours.

Granberg, Dan; Sundin, Anders; Tiensuu Janson, Eva; Oberg, Kjell et al.

Part of Clin Endocrinol (Oxf), p. 793-9, 2003

A comparison between three commercial kits for chromogranin Ameasurements.

Stridsberg, M; Eriksson, B; Oberg, K; Tiensuu Janson, E

Part of J Endocrinol, p. 337, 2003

Neuroendocrine tumors--somatostatin receptor expression and somatostatin analog treatment.

Tiensuu Janson, E; Öberg, Kjell

Part of Cancer Chemother Biol Response Modif, p. 535-46, 2003

Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases.

Hellman, P; Lundstrom, T; Ohrvall, U; Eriksson, B et al.

Part of World J Surg, p. 991, 2002

Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.

Fjällskog, M L; Sundin, A; Westlin, J E; Öberg, K et al.

Part of Med Oncol, p. 35-42, 2002

Levels of angiogenic peptides in sera from patients with carcinoid tumoursduring alpha-interferon treatment.

Nilsson, A; Tiensuu Janson, E; Eriksson, B; Larsson, A

Part of Anticancer Res., p. 4087, 2001

Novel long-acting somatostatin analog with endocrine selectivity: potentsuppression of growth hormone but not of insulin.

Afargan, M; Tiensuu Janson, E; Gelerman, G; Rosenfeld, R et al.

Part of Endocrinology, p. 477, 2001

Treatment with cisplatin and etoposide in patients with neuroendocrinetumors.

Fjallskog, ML; Granberg, DP; Welin, SL; Eriksson, C et al.

Part of Cancer, p. 1101, 2001

Transmembrane protein tyrosine phosphatase IA-2 (ICA512) is expressed inhuman midgut carcinoids but is not detectable in normal enterochromaffincells.

Cunningham, JL; Lopez-Egido, JR; Tiensuu Janson, E; Eriksson, B et al.

Part of J Endocrinol, p. 315, 2000

Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas

Portela-Gomes, G M; Stridsberg, Mats; Grimelius, Lars; Oberg, Kjell et al.

Part of Appl. Immunohistochem., p. 126, 2000

Nuclear localization of 111In after intravenous injection of 111In-DTPA-D-Phe-1-octreotide to patients with neuroendocrine tumors.

Tiensuu Janson, E; Westlin, JE; Öhrvall, U; Öberg, K et al.

Part of J Nuclear Medicine, p. 1514, 2000

Tumour markers in neuroendocrine tumours

Oberg, Kjell; Tiensuu Janson, E; Eriksson, undefined

Part of Ital J Gastroenterol Hepatol, p. 160, 1999

In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complex

Lukinius, Agneta; Ohrvall, U; Westlin, Jan Eric; Oberg, Kjell et al.

Part of Acta Oncol., p. 383, 1999

The somatostatin analog octreotide inhibits growth of interleukin-6 (IL-dent and IL-6-independent human multiple myeloma cell lines.

Georgii-Hemming, P; Stromberg, T; Tiensuu Janson, E; Stridsberg, M et al.

Part of Blood, p. 1724, 1999

Somatostatin receptor ligands and their use in the treatment of endocrine disorders

Tiensuu Janson, E; Oberg, Kjell

Part of Curr Pharm Des, p. 693, 1999

Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization?

Skogseid, Britt; Öberg, Kjell; Åkerström, Göran; Eriksson, Barbro et al.

Part of World Journal of Surgery, p. 673-677; discussion 667-668, 1998

• DOI for Limited tumor involvement found at multiple endocrine neoplasia type I pancreatic exploration: can it be predicted by preoperative tumor localization?

Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies.

Tiensuu Janson, E; Stridsberg, M; Gobl, A; Westlin, J E et al.

Part of Cancer Res, p. 2375-8, 1998

Expression of p68 protein kinase and its prognostic significance during IFN-a therapy in patients with carcinoid tumors

Zhou, Yinghua; Gobl, Anders; Wang, Shu; Jacobsen, M B et al.

Part of Eur J Cancer, p. 2046, 1998

Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center

Tiensuu Janson, Eva; Holmberg, Lars; Stridsberg, Mats; Eriksson, Barbro et al.

Part of Annals of Oncology, p. 685-690, 1997

• DOI for Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center

Induction of apoptosis in neuroendocrine tumors of digestive system during treatment with somatostatin analogs.

Imam, Hassan; Eriksson, Barbro; Lukinius, Agneta; Tiensuu Janson, Eva et al.

Part of Acta Oncol., p. 60714, 1997

The use of new somatostatin analogues, lanreotide and octastatin, inneuroendocrine gastro-intestinal tumours.

Eriksson, Barbro; Tiensuu Janson, E; Bax, ND; Mignon, M et al.

Part of Digestion, p. 77, 1996

A comparison between the efficacy of somatostatin receptor scintigraphy and in situ hybridization for somatostatin receptor subtype 2 mRNA to predict therapeutic outcome in carcinoid patients

Tiensuu Janson, E; Gobl, Anders; Kalkner, M; Oberg, Kjell

Part of Cancer Research, p. 2561, 1996

Induction of MxA-mRNA in patients with neuroendocrine tumors after interferon treatment - lack of correlation to antitumor response.

Imam, Hassan; Tiensuu Janson, Eva; Gobl, Anders; Alm, Gunnar et al.

Part of Anti-Cancer Research, p. 2191, 1995

Somatostatin receptor scintigraphy in patients with carcinoid tumors: Comparison between radioligand uptake and tumor markers.

Kalkner, Karl Mikael; Tiensuu Janson, Eva; Nilsson, S; Carlsson, S et al.

Part of Cancer Research, p. 5801, 1995

Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience

Sorbe, Bengt; Andersson, Håkan; Schmidt, Margareta; Söderberg, Martin et al.

Part of Supportive Care in Cancer, p. 393-399, 1994

• DOI for Tropisetron (Navoban) in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience

[111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment

Tiensuu Janson, Eva; Westlin, J E; Eriksson, B; Ahlström, Håkan et al.

Part of European Journal of Endocrinology, p. 577-581, 1994

• DOI for [111In-DTPA-D-Phe1]octreotide scintigraphy in patients with carcinoid tumours: the predictive value for somatostatin analogue treatment

Treatment with alpha-interferon versus alpha-interferon in combinationwith streptozocin and doxorubicin in patients with malignant carcinoidtumors: a randomized trial

Tiensuu Janson, Eva; Rönnblom, Lars; Ahlström, Håkan; Grander, D et al.

Part of Annals of Oncology, p. 635-638, 1992

Characterization of anti-interferon-alpha antibodies appearing duringrecombinant interferon-alpha 2a treatment.

Ronnblom, LE; Tiensuu Janson, E; Perers, A; Oberg, KE et al.

Part of Clin Exp Immunol, p. 330, 1992

[New medical therapy of neuroendocrine gastrointestinal tumors]

Eriksson, B; Janson, E T; Skogseid, B; Oberg, K

Part of Lakartidningen, p. 2668-72, 1990

Interferon-induced enhancement of 2',5'-oligoadenylate synthetase in mid-gut carcinoid tumours.

Grander, D; Oberg, K; Lundqvist, M L; Tiensuu Janson, E et al.

Part of Lancet, p. 337-40, 1990

Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

Janson, Eva Tiensuu; Sorbye, Halfdan; Welin, Staffan; Federspiel, Birgitte et al.

Part of Acta Oncologica, p. 1284-1297, 2014

• DOI for Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms

The biological hallmarks of ileal carcinoids

Cunningham, Janet L.; Janson, Eva T.

Part of European Journal of Clinical Investigation, p. 1353-1360, 2011

• DOI for The biological hallmarks of ileal carcinoids

Treatment of neuroendocrine tumors with somatostatin analogs

Janson, Eva Tiensuu

Part of Pituitary, p. 249-256, 2006

• DOI for Treatment of neuroendocrine tumors with somatostatin analogs

Somatostatin analogs in the treatment of neuroendocrine gastroenteropancreatic and intrathoracic tumors

Janson, Eva Tiensuu

Part of Journal of Endocrinological Investigation, p. 137-140, 2005

Tratamento dos tumores endócrinos do pâncreas.

Fjällskog, Marie-Louise; Janson, Eva Tiensuu

Part of Câncer Hoje- A Oncologia baseada em Evidência., p. 17-25, 2004

Carcinoid Tumors

Janson, Eva Tiensuu; Öberg, Kjell

Part of Hematology-oncology therapy, p. 72-79, McGraw-Hill, 2007

The carcinoid syndrome

Tiensuu Janson, E; Öberg, K

Part of Gastroenterology and Hepatology: the Modern Clinician's Guide, p. 823-830, Weinstein WM, Hawkey CJ and Bosch J, 2005

Diseases of the gut and liver: The carcinoid syndrome

Öberg, Kjell; Tiensuu Janson, Eva

Part of Clinical Gastroenterology and Hepatology, p. 823, Elsevier Mosby, 2005

Malignant neuroendocrine tumors.

Tiensuu Janson, E; Oberg, K

Part of Cancer Chemother Biol Response Modif, p. 463, 2002

Clinical GastroenterologyCarcinoid tumours.

Tiensuu Janson, E; Oberg, K

1996

Carcinoid tumours

Tiensuu Janson, E; Oberg, K

Part of Clinical Gastroenterology, 1996

Novel Serum Biomarkers in Small Intestinal Neuroendocrine Tumors

Edfeldt, Katarina; Bäcklin, Christofer; Tiensuu Janson, Eva; Westin, Gunnar et al.

Phosphohistone H3 and Ki-67 as prognostic markers in metastatic small intestinal neuroendocrine tumours: A comparative, retrospective, cohort study.

Papantoniou, Dimitrios; Grönberg, Malin; Tiensuu Janson, Eva

Neuroendocrine tumors-Somatostatin receptors and treatment

Tiensuu Janson, Eva; Öberg, Kjell

Part of Austral-Asian Journal of Cancer, p. 51-59, 2004